Asset Details
- Identifier:
- cbdd13536-fig-0008
- Description:
- (a) The best predicted pose of dichlorophen (red) along with its para derivative MN02 (pink). (b) The best predicted pose of bithionol (brown) along with its para derivative resorcinol sulfide (green). The reference ligand triclosan is shown as blue sticks in both pictures, and the active site of the ecFabI‐NAD complex is shown as blue ribbon [Colour figure can be viewed at wileyonlinelibrary.com]
- License:
- Rights Managed
- Rights Holder:
- John Wiley & Sons, Inc.
- License Rights Holder:
- Copyright © 2019 John Wiley & Sons A/S
- Asset Type:
- Image
- Asset Subtype:
- Chart/Graph
- Image Orientation:
- Landscape
- Image Dimensions:
- 2128 x 844
- Image File Size:
- 1.15 MB
- Creator:
- Mohammad A. Ghattas, Nermin A. Eissa, Francesca Tessaro, Remo Perozzo, Leonardo Scapozza, Dana Obaid, Noor Atatreh
- Credit:
- Ghattas, M., Eissa, N., & Tessaro, F. (2019). Structure‐based drug design and in vitro testing reveal new inhibitors of enoyl‐acyl carrier protein reductases. Chemical Biology & Drug Design, 94(2), 1545-1555. https://doi.org/10.1111/cbdd.13536.
- Collection:
- Keywords:
- Restrictions:
- Property Release:
- No
- Model Release:
- No
- Purchasable:
- Yes
- Sensitive Materials:
- No
- Article Title:
- Structure‐based drug design and in vitro testing reveal new inhibitors of enoyl‐acyl carrier protein reductases
- Article Authors:
- Mohammad A. Ghattas, Nermin A. Eissa, Francesca Tessaro, Remo Perozzo, Leonardo Scapozza, Dana Obaid, Noor Atatreh
- Article Copyright Year:
- 2019
- Publication Title:
- Chemical Biology & Drug Design
- Publication Volume:
- 94
- Publication Issue:
- 2
- Publication Date:
- 08/01/2019
- DOI:
- https://doi.org/10.1111/cbdd.13536
Click on image to enlarge
